New Zealand markets open in 9 hours 20 minutes

Finch Therapeutics Group, Inc. (FNCH)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
1.3500+0.1100 (+8.87%)
At close: 01:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
107
861
18,532
7,719
-
Cost of revenue
-
-
-
-
0
314
Gross profit
-
-
-
-
7,719
9,840
Operating expenses
Research development
203
7,199
52,863
57,279
33,144
-
Selling general and administrative
22,457
26,910
36,192
21,238
14,011
-
Total operating expenses
22,660
34,109
89,055
78,517
47,155
-
Operating income or loss
-22,660
-34,002
-88,194
-59,985
-39,436
-
Total other income/expenses net
4,952
-45,783
-26,704
1,803
-11
-
Income before tax
-16,283
-78,215
-114,646
-58,160
-39,341
-
Income tax expense
0
-3,461
0
0
0
-
Income from continuing operations
-16,283
-74,754
-114,646
-58,160
-39,341
-
Net income
-16,283
-74,754
-114,646
-58,160
-39,341
-
Net income available to common shareholders
-16,283
-74,754
-114,646
-58,160
-39,341
-
Basic EPS
-61.48
-46.59
-72.12
-44.40
-25.72
-
Diluted EPS
-61.48
-46.59
-72.12
-44.40
-25.72
-
Basic average shares
1,603
1,605
1,590
1,307
1,530
-
Diluted average shares
1,603
1,605
1,590
1,307
1,530
-